JBM (Healthcare) Limited (2161.HK)
HKD 2.0
(-3.38%)
HKD 2.0
(-3.38%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 43.8 Million HKD | -31.35% |
| 2022 | 63.8 Million HKD | -44.52% |
| 2021 | 115 Million HKD | -34.29% |
| 2020 | 175 Million HKD | -60.81% |
| 2019 | 446.51 Million HKD | 5561.4% |
| 2018 | 7.88 Million HKD | -32.38% |
| 2017 | 11.66 Million HKD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 FY | 43.8 Million HKD | -31.35% |
| 2023 Q2 | 53.8 Million HKD | 0.0% |
| 2023 Q4 | 43.8 Million HKD | 0.0% |
| 2022 Q4 | 63.8 Million HKD | 0.0% |
| 2022 FY | 63.8 Million HKD | -44.52% |
| 2022 Q2 | 100 Million HKD | 0.0% |
| 2021 Q2 | 145 Million HKD | 0.0% |
| 2021 FY | 115 Million HKD | -34.29% |
| 2021 Q4 | 115 Million HKD | 0.0% |
| 2020 Q2 | - HKD | -100.0% |
| 2020 Q4 | 175 Million HKD | 0.0% |
| 2020 Q1 | 378.4 Million HKD | 0.0% |
| 2020 FY | 175 Million HKD | -60.81% |
| 2019 FY | 446.51 Million HKD | 5561.4% |
| 2018 FY | 7.88 Million HKD | -32.38% |
| 2017 FY | 11.66 Million HKD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | -2012.881% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | 95.576% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | 62.604% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | 84.142% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | 37.992% |
| Essex Bio-Technology Limited | 36.05 Million HKD | -21.475% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | -242.161% |
| PuraPharm Corporation Limited | 81.09 Million HKD | 45.988% |
| SSY Group Limited | 1.94 Billion HKD | 97.751% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | 92.604% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 99.736% |